Pressreleaser

• 2022-07-07 Non-regulatorisk

  NeoDynamics receives ethical approval for German device registry

  Läs mer här

• 2022-06-17 Non-regulatorisk

  Gryningskust Holding AB increases ownership in NeoDynamics

  Läs mer här

• 2022-06-09 Non-regulatorisk

  Update on the FDA approval process for NeoNavia®

  Läs mer här

• 2022-05-24 Regulatorisk

  Communiqué from the annual general meeting in NeoDynamics AB (publ)

  Läs mer här

• 2022-05-18 Non-regulatorisk

  NeoDynamics Newsletter, May 2022

  Läs mer här

• 2022-05-17 Regulatorisk

  New data from NeoDynamics’ PULSE study presented at major US breast imaging conference

  Läs mer här

• 2022-05-12 Regulatorisk

  NeoDynamics AB (publ) first quarter 2022

  Läs mer här

• 2022-05-02 Non-regulatorisk

  Trading in NeoDynamics shares on Nasdaq First North starts today

  Läs mer här

• 2022-04-28 Regulatorisk

  NeoDynamics publishes supplementary document introducing listing on Nasdaq First North Growth Market

  Läs mer här

• 2022-04-27 Regulatorisk

  NeoDynamics publishes Annual Report 2021

  Läs mer här

• 2022-04-26 Regulatorisk

  Last day of trading in paid subscription shares (Sw.BTA)

  Läs mer här

• 2022-04-13 Regulatorisk

  NeoDynamics conditionally approved for listing on Nasdaq First North

  Läs mer här

• 2022-03-28 Regulatorisk

  NeoDynamics announces outcome of rights issue

  Läs mer här

• 2022-03-15 Non-regulatorisk

  NeoDynamics sets up NeoDynamics USA Inc.

  Läs mer här

• 2022-03-01 Non-regulatorisk

  NeoDynamics has filed for registration of NeoNavia® in the US

  Läs mer här

• 2022-02-25 Regulatorisk

  Communique from extraordinary general meeting in NeoDynamics AB (publ)

  Läs mer här

• 2022-02-16 Non-regulatorisk

  NeoDynamics to present Q4 report on Feb 21 at 12.30

  Läs mer här

• 2022-02-16 Regulatorisk

  NeoDynamics AB (publ) full-year report 2021

  Läs mer här

• 2022-02-09 Regulatorisk

  Notice of extraordinary general meeting in NeoDynamics AB

  Läs mer här

• 2022-01-24 Non-regulatorisk

  Interview and company presentation in collaboration with Uddaaktier

  Läs mer här

• 2022-01-20 Non-regulatorisk

  New data from NeoDynamics PULSE study accepted for presentation at major US breast imaging conference

  Läs mer här

• 2022-01-17 Non-regulatorisk

  NeoDynamics to present at Redeye Fight Cancer Seminar 20 Jan 2022

  Läs mer här